Clinical Trial

Sex Differences in Neurobehavioral Response to THC

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
This study investigates sex differences in reward processing following acute THC administration in adults with cannabis use disorder (CUD). Using multimodal neuroimaging (MRS and fMRI), the study will assess glutamate levels in the nucleus accumbens and striatal BOLD response to monetary reward anticipation. Participants will complete two counterbalanced dosing sessions (oral THC 40 mg vs. placebo).
Protocol Amendment History 1 change
critical Recruitment opened 2026-05-07
Trial Details
NCT Number NCT07225777
Lead Sponsor Medical University of South Carolina
Collaborators: National Institutes of Health (NIH), National Institute on Drug Abuse (NIDA)
Conditions Cannabis Use Disorder
Enrollment 40 participants
Start Date 2026-04-27
Primary Completion 2027-12-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-05-06